Y
Yihuai Gao
Researcher at Massey University
Publications - 30
Citations - 2245
Yihuai Gao is an academic researcher from Massey University. The author has contributed to research in topics: Cancer & Ganoderma. The author has an hindex of 22, co-authored 30 publications receiving 2094 citations.
Papers
More filters
Journal ArticleDOI
Interactions of herbs with cytochrome P450.
TL;DR: Given that increasing numbers of people are exposed to a number of herbal preparations that contain many constituents with potential of CYP modulation, high-throughput screening assays should be developed to explore herb–CYP interactions.
Journal ArticleDOI
Herbal bioactivation: The good, the bad and the ugly
TL;DR: The role of the formation of reactive metabolites/intermediates through bioactivation in herbal toxicity and carcinogenicity has been well established as mentioned in this paper, leading to toxicity via multiple mechanisms such as direct cytotoxicity, oncogene activation and hypersensitivity reactions.
Journal ArticleDOI
Effects of Ganopoly® (A Ganoderma lucidum Polysaccharide Extract) on the Immune Functions in Advanced‐Stage Cancer Patients
TL;DR: It is indicated that Ganopoly®, the polysaccharides fractions extracted from G. lucidum, enhanced the immune responses in patients with advanced‐stage cancer.
Polysaccharide Extract) on the Immune Functions in Advanced-Stage Cancer Patients
TL;DR: Wang et al. as mentioned in this paper investigated the effects of Ganopoly on immuno-modulating effects in humans in vivo, and found that the Ganoderma lucidum polysaccharide (GLPS) fractions have potent anti-tumor activity.
Journal ArticleDOI
Antitumor Activity and Underlying Mechanisms of Ganopoly, The Refined Polysaccharides Extracted from Ganoderma Lucidum, in Mice
Yihuai Gao,He Gao,Eli Chan,Wenbo Tang,Anlong Xu,Hongyuan Yang,Min Huang,Jin Lan,Xiaotian Li,Wei Duan,Congjian Xu,Shu-Feng Zhou +11 more
TL;DR: The overall findings indicated that Ganopoly had antitumor activity with a broad spectrum of immuno-modulating activities and may represent a novel promising immunotherapeutic agent in cancer treatment.